Neiges Biotechnologies Overview

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 6

Neiges Biotechnologies General Information

Description

Developer of patient-derived tissue models designed for drug discovery and preclinical research. The company's platform produces intestinal tissue models from patient stem cells, supports molecular and cellular analysis, enables parallel testing of multiple compounds on matched samples, and generates reproducible experimental data, enabling pharmaceutical and biotechnology organizations to evaluate drug candidates and study biological responses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1250 Rue Guy
  • Suite 600
  • Montreal, Quebec H3H 2L3
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1250 Rue Guy
  • Suite 600
  • Montreal, Quebec H3H 2L3
  • Canada

Neiges Biotechnologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neiges Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round Completed Startup
6. Accelerator/Incubator 01-Jan-2026 Completed Startup
5. Accelerator/Incubator 08-Sep-2025 Completed Startup
4. Accelerator/Incubator 28-May-2025 Completed Startup
3. Grant 03-Mar-2025 Completed Startup
2. Accelerator/Incubator 01-Oct-2023 Completed Startup
1. University Spin-Out Completed Startup
To view Neiges Biotechnologies’s complete valuation and funding history, request access »

Neiges Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neiges Biotechnologies Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Merck Digital Sciences Studio Accelerator/Incubator Minority
District 3 Innovation Center Accelerator/Incubator
McGill University University
V1 Studio Accelerator/Incubator
Front Row Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Neiges Biotechnologies FAQs

  • Where is Neiges Biotechnologies headquartered?

    Neiges Biotechnologies is headquartered in Montreal, Canada.

  • What is the size of Neiges Biotechnologies?

    Neiges Biotechnologies has 3 total employees.

  • What industry is Neiges Biotechnologies in?

    Neiges Biotechnologies’s primary industry is Drug Discovery.

  • Is Neiges Biotechnologies a private or public company?

    Neiges Biotechnologies is a Private company.

  • What is Neiges Biotechnologies’s current revenue?

    The current revenue for Neiges Biotechnologies is .

  • How much funding has Neiges Biotechnologies raised over time?

    Neiges Biotechnologies has raised $110K.

  • Who are Neiges Biotechnologies’s investors?

    Merck Digital Sciences Studio, District 3 Innovation Center, McGill University, V1 Studio, and Front Row Ventures are 5 of 6 investors who have invested in Neiges Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process